article thumbnail

DEA Discusses Legal Status Of Minor Cannabinoids Like THCA And Hydrogenated CBD

Cannabis Law Report

Marijuana Moment The Drug Enforcement Administration (DEA) is weighing in on the legal status of lesser known cannabinoids such as THCA, delta-8 THC and hydrogenated CBD.

DEA 98
article thumbnail

THCO is a Controlled Substance: DEA

Cannabis Life Network

The Drug Enforcement Administration (DEA) says Delta-8 and -9 THCO are controlled substances, even when derived from hemp. The DEA said that Delta-8 and -9 THCO “do not occur naturally in the cannabis plant and can only be obtained synthetically, and therefore do not fall under the definition of hemp.”

DEA 76
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DEA Official Says New Rules Are Coming For Synthetic Cannabinoids, Including CBD And Delta-8 THC

Cannabis Law Report

Marijuana Moment reports The Drug Enforcement Administration (DEA) will soon be proposing new rules to clarify that synthetically manufactured cannabinoids like delta-8 THC are prohibited controlled substances.

DEA 59
article thumbnail

The DEA Plans to Reschedule Marijuana: What Happens Next?

Medical Marijuana Program Connection

The US Drug Enforcement Agency (DEA) is moving forward with plans to move marijuana from a Schedule I to a Schedule III controlled substance under the Controlled Substance Act (CSA), the US Department of Justice officials announced this week. First reported by the Associated Press and since confirmed by Medscape. Read More

DEA 53
article thumbnail

Cannabinoid Breakdown- Analyzing the DEA’s Position on Novel Cannabinoids

Cannabis Law Report

Despite its brevity, the DEA letter I received last week about THCO was followed by confusion and lots of speculation in the cannabis industry about the legal status of novel and mood-altering cannabinoids. In this article, I […]

article thumbnail

‘The most meaningful cannabis reform in decades’: Experts weigh in on new DEA rules

The Cannigma

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. Shutterstock).

DEA 133
article thumbnail

‘The Doors are Wide Open’: Denver Cannabis Company Gets DEA Approval To Expand Alzheimer’s Research

Cannabis Law Report

The Denver cannabis company MedPharm can now ramp up its research into the effects marijuana has on Alzheimer’s disease. According to Towle, MedPharm’s researchers hope to find whether cannabinoids can treat symptoms or even prevent the disease. The new DEA research license will now change that. credit: CBS). credit: CBS).

DEA 105